CSA Biotechnologies
PrivateCompany Overview
CSA Biotechnologies operates in Healthcare & Life Sciences and is based in Chandler, Arizona. It was founded in 2012.
CSA Biotechnologies is a clinical-stage biotechnology company that develops ceragenin-based therapeutics for the treatment of Epidermolysis Bullosa and other conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CSA Biotechnologies Comparables
Compare CSA Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phoenicis Therapeutics | 85% | |
| BioMendics | 84% | |
| Aegle Therapeutics Corp | 83% |
For institutional investors. Book with your work email.
CSA Biotechnologies Funding Rounds
Historical fundraising activity
CSA Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CSA Biotechnologies's valuation, stock price, and market status.
Is CSA Biotechnologies a public or private company?
CSA Biotechnologies is a private company.
What is the current stock price of CSA Biotechnologies?
CSA Biotechnologies is a private company, so its shares have no public market price. Caplight tracks CSA Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CSA Biotechnologies worth (valuation)?
Valuation information for CSA Biotechnologies is not publicly available.
Can I buy CSA Biotechnologies stock?
CSA Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CSA Biotechnologies's last funding round?
Funding round information for CSA Biotechnologies is not publicly available.
Who are the main investors in CSA Biotechnologies?
Investor information for CSA Biotechnologies is not publicly disclosed.
Will CSA Biotechnologies IPO soon?
No public IPO plans have been announced for CSA Biotechnologies.
How can I track CSA Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in CSA Biotechnologies's shares on secondary markets.